Bill Gates Makes Announcement on mRNA ‘Vaccine’ Development
Bill Gates announced at the 2023 Grand Challenges Annual Meeting a $40 million investment to push toxic mRNA gene therapies in Africa.
The Bill & Melinda Gates Foundation said the investment will “advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries’ (LMICs) capacity to develop high-quality, lifesaving vaccines at scale.”
Bill Gates is now giving $40 MILLION to develop and push for mRNA vaccines in Africa.
— PeterSweden (@PeterSweden7) October 12, 2023
Do you trust him?
The Associated Press noted Africa was the last continent in line to receive the experimental COVID-19 mRNA injections.
Should we remind the ‘experts’ that Africa had one of the lowest COVID-19 mortality rates?
The NIH Library states:
The impact of COVID-19 in Africa has been substantially lower compared to countries in the Americas, Europe, and Asia. The World Health Organization (WHO) African Region reported more than 3.9 million confirmed cases and 94,217 deaths, as of June 27, 2021.5 Moreover, the mortality rate of COVID-19 per million in Africa is considerably lower than in all other WHO regions other than the Western Pacific
Yet, Bill Gates will try his hardest to ‘convince’ the continent to accept mRNA vaccines.
The Associated Press reports:
While it could still take at least three more years before any of the vaccines are approved and on the market, the foundation said that its mRNA investment marks an important step forward in improving vaccine equity.
“Whether it’s for local diseases in Africa like Rift Valley (fever) or for global diseases like TB, mRNA looks like a very promising approach,” Bill Gates told The Associated Press on Sunday after visiting one of the facilities involved, the Institut Pasteur in Dakar, Senegal. “And so it allows us to bring in lots of African capabilities to work on these vaccines, and then this can be scaled up.”
The announcement comes as the foundation opens its annual three-day Grand Challenges event, which brings together scientists and public health researchers from around the world.
Institut Pasteur, along with the South Africa-based company Biovac, will be using an mRNA research and manufacturing platform that was developed by Quantoom Biosciences in Belgium. The two Africa-based vaccine manufacturers are receiving $5 million each in funding from the foundation, while another $10 million is earmarked for other companies that have not yet been named. The remaining $20 million is going to Quantoom “to further advance the technology and lower costs.”
Bill Gates Investing $40 Million for mRNA Vaccine Development in Africa
— The Epoch Times (@EpochTimes) October 10, 2023
The investment will fund new technologies that cut down mRNA vaccine costs by over 50 percent.https://t.co/khKwn0szMG
Read More Here: 100 % Fed UP
Posts
